Background Loop diuretics are an essential component of therapy for patients with acute
decompensated heart failure, but there are few prospective data to guide their use. Methods In …

of Key Points In this document, we propose a universal definition of heart failure (HF) as the
following: HF is a clinical syndrome with symptoms and or signs caused by a structural and/…

Background Previous studies of the prognosis of patients with heart failure due to cardiomyopathy
categorized patients according to whether they had ischemic or nonischemic disease. …

Importance Studies in experimental and human heart failure suggest that phosphodiesterase-5
inhibitors may enhance cardiovascular function and thus exercise capacity in heart …

Background Nesiritide is approved in the United States for early relief of dyspnea in patients
with acute heart failure. Previous meta-analyses have raised questions regarding renal …

Background Ultrafiltration is an alternative strategy to diuretic therapy for the treatment of
patients with acute decompensated heart failure. Little is known about the efficacy and safety of …

Objectives : The goal of this study was to identify potentially novel laboratory markers of risk
in chronic heart failure patients. Background : Although a variety of prognostic markers have …

Background Serelaxin, recombinant human relaxin-2, is a vasoactive peptide hormone with
many biological and haemodynamic effects. In a pilot study, serelaxin was safe and well …

Objectives : The goal of this study was to assess the interaction between heart failure (HF)
etiology and response to milrinone in decompensated HF. Background : Etiology has …

The goal of this study was to examine the frequency of mitral regurgitation (MR) in patients
with left ventricular (LV) systolic dysfunction and to relate its presence and severity to long-…